hypertension
Both ET-1 receptor antagonists bosentan and LU135252 were       effective in attenuating the progression of hypertension in uremic rats receiving       the vehicle (P < 0.05).
Both ET-1 receptor antagonists bosentan and LU135252 were       effective in attenuating the progression of  @SUBJECT$   @PREDICAT$  uremic  @OBJECT$  receiving       the vehicle (P < 0.05).